112 related articles for article (PubMed ID: 34672208)
21. Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients.
Rigamonti A; Imbesi F; Silvani A; Gaviani P; Agostoni E; Porcu L; De Simone I; Torri V; Salmaggi A
J Neurol Sci; 2018 Jul; 390():14-19. PubMed ID: 29801876
[TBL] [Abstract][Full Text] [Related]
22. Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI.
Romano A; Pasquini L; Di Napoli A; Tavanti F; Boellis A; Rossi Espagnet MC; Minniti G; Bozzao A
J Neurooncol; 2018 Sep; 139(2):455-460. PubMed ID: 29721752
[TBL] [Abstract][Full Text] [Related]
23. Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
Li G; Zhai Y; Wang Z; Wang Z; Huang R; Jiang H; Li R; Feng Y; Chang Y; Jiang T; Zhang W
Cancer Med; 2020 Mar; 9(6):1955-1965. PubMed ID: 31851783
[TBL] [Abstract][Full Text] [Related]
24. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G
Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432
[TBL] [Abstract][Full Text] [Related]
25. Body mass index as an independent prognostic factor in glioblastoma.
Valente Aguiar P; Carvalho B; Vaz R; Linhares P
Cancer Causes Control; 2021 Apr; 32(4):327-336. PubMed ID: 33447892
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
Niyazi M; Schwarz SB; Suchorska B; Belka C
Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.
Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z
World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530
[TBL] [Abstract][Full Text] [Related]
28. Conditional probability of survival in patients with newly diagnosed glioblastoma.
Polley MY; Lamborn KR; Chang SM; Butowski N; Clarke JL; Prados M
J Clin Oncol; 2011 Nov; 29(31):4175-80. PubMed ID: 21969507
[TBL] [Abstract][Full Text] [Related]
29. [Results of postoperative radiochemotherapy of glioblastoma multiforme].
Lövey J; Fedorcsák I; Bajcsay A; Sipos L; Mangel L; Kásler M; Bagó A
Magy Onkol; 2013 Dec; 57(4):232-9. PubMed ID: 24353988
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma.
Wu CX; Lin GS; Lin ZX; Zhang JD; Liu SY; Zhou CF
World J Surg Oncol; 2015 Mar; 13():97. PubMed ID: 25886608
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
[TBL] [Abstract][Full Text] [Related]
32. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
33. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Survival Prediction in Patients With Glioblastoma by Routine Inflammatory Laboratory Parameters.
Pierscianek D; Ahmadipour Y; Michel A; Chihi M; Oppong MD; Kebir S; Glas M; Stuschke M; Sure U; Jabbarli R
Anticancer Res; 2020 Feb; 40(2):1161-1166. PubMed ID: 32014969
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?
Dobran M; Nasi D; Chiriatti S; Gladi M; Somma LD; Iacoangeli M; Scerrati M
Neurol Med Chir (Tokyo); 2018 Mar; 58(3):110-115. PubMed ID: 29343677
[TBL] [Abstract][Full Text] [Related]
36. MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.
Shen D; Liu T; Lin Q; Lu X; Wang Q; Lin F; Mao W
PLoS One; 2014; 9(9):e107558. PubMed ID: 25211033
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.
Stark AM; van de Bergh J; Hedderich J; Mehdorn HM; Nabavi A
Clin Neurol Neurosurg; 2012 Sep; 114(7):840-5. PubMed ID: 22377333
[TBL] [Abstract][Full Text] [Related]
38. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
[TBL] [Abstract][Full Text] [Related]
39. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.
Filippini G; Falcone C; Boiardi A; Broggi G; Bruzzone MG; Caldiroli D; Farina R; Farinotti M; Fariselli L; Finocchiaro G; Giombini S; Pollo B; Savoiardo M; Solero CL; Valsecchi MG;
Neuro Oncol; 2008 Feb; 10(1):79-87. PubMed ID: 17993634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
